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Despite the increasing burden of alcohol dependence, treatment resources in low- and middle-
income countries such as India, are concentrated in poorly accessible tertiary care facilities. The 
aim of our study was to examine the feasibility and cceptability of lay health worker delivered 
home-based packages of care for alcohol dependence. We conducted an uncontrolled treatment 
cohort with alcohol dependent adult males recruited in primary and secondary care. Lay health 
workers delivered home-detoxification and/or relapse revention counselling. Process data was 
analysed using descriptive statistics. 11 men with alcohol dependence received home 
detoxification and relapse prevention counselling and 27 received only relapse prevention 
counselling. Of the 11 receiving home detoxification, ne participant re-started drinking; all the 
rest safely completed the home detoxification. During detoxification, the pulse, blood pressure 
and temperature remained within the normal range and ataxia, dehydration, disorientation, 
sleep normalised over the course of the detoxificaton. Of the 38 who entered relapse 
prevention treatment, 15 (39.5%) completed treatmen or had a planned discharge. The mean 
number of sessions was 2.4 (SD=1.3); those who had a planned discharge received on an 
average 3.7 (SD 0.5) sessions and those who dropped out received on an average 1.4 (SD 0.8) 
sessions.  There was no significant change in daily alcohol consumption and percentage days of 
heavy drinking (PDHD) between baseline and follow-up in the whole cohort. The SIP score 
reduced significantly in the whole cohort (24.5 vs 15.0, p=0.002), and also when segregated by 
treatment settings, and type of treatment package rec ived. With appropriate adaptations, our 
intervention warrants further research as it has the potential to bridge the significant treatment 
gap for alcohol dependence in low- and middle- income countries. 
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Alcohol use is linked causally to several disease and injury categories, with more than 
40 WHO International Statistical Classification of Diseases and Related Health 
Problems, 10th revision (ICD‐10) categories being fully attributable to alcohol (Rehm 
et al., 2017). Among all mental and substance disorers, alcohol use disorders (AUDs) 
are one of the leading causes of disability, and the largest contributor to premature 
mortality; and overall one of the five leading risk factors for adult chronic disease 
(Forouzanfar et al., 2016; Vos et al., 2017). In India, there are high rates of alcohol-
attributable mortality and prevalence of AUDs, relative to the per capita volume of 
alcohol consumed (Benegal, 2005; Rehm et al., 2009). 
 
Alcohol dependence, the most severe form of AUD, is a direct cause of premature 
death and disability, and a risk factor for other communicable (e.g. tuberculosis and 
HIV) and non-communicable (e.g. hypertension and stroke) diseases (Holst et al., 2017; 
Rehm et al., 2017; Schoepf & Heun, 2015; Wood et al., 2018). It also impacts multiple 
domains of the affected person’s life, including reduced productivity, job loss or 
absenteeism, loss of relationships, problems with family roles, vandalism, social drift 
downwards and stigma. The official response in India to the growing public health 
problem of alcohol dependence remains focused primarily on funding tertiary care 
services. However, such services are scarce, resource-intensive, and often difficult to 
access because of financial or geographical factors (Dhawan et al., 2017; National 
Collaborating Centre for Mental Health, 2011), and certainly not indicated for less 
severely dependent patients (Day et al., 2015; Nation l Collaborating Centre for Mental 
Health, 2011; Spithoff et al., 2015). For instance, many of the detoxification and 
‘counselling’ centres that fall under the remit of the National Drug De-addiction 
Programme (Prasad, 2009) in India are defunct and the existing centres are not 
adequate to address the psychosocial needs of patients and their families (Dhawan et 
al., 2017; Mattoo et al., 2015; Prasad, 2009). Hence, the treatment of alcohol 
dependence in existing platforms of institutional cre in India is both limited by its 
accessibility, and sub-optimal, because community-based care is rarely available 
despite it being recommended in most cases (National Collaborating Centre for Mental 
Health, 2011) as both a viable and efficient solutin (Ibrahim and Gilvarry, 2005). As a 
result, a large proportion of people with AUD in India do not have access to help for 
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their alcohol related problems, leading to a high treatment gap of 86% (Gururaj et al., 
2016). 
 
Efficient utilisation of limited resources for treatment of mild to moderate dependence 
involves community-based treatment through home-basd assisted withdrawal 
programs involving fixed dose medication regimens whenever indicated, a carer 
overseeing the process with daily monitoring by trained staff, and psychosocial support 
(National Collaborating Centre for Mental Health, 2011). Such a program, based on the 
principle of collaborative care, overcomes challenges related to accessibility and 
acceptability of treatment, that are often found in low resource settings (Nadkarni & 
Bhatia, 2019; Wright et al., 2018). However, there is no robust evidence about the 
acceptability, feasibility and effectiveness of community-based detoxification in low- 
and middle-income countries (LMICs) (Nadkarni et al., 2017a). 
 
The aim of CONTAD (Community Orientated Non-specialist Treatment of Alcohol 
Dependence), a community program for alcohol dependence, was to systematically 
develop a lay health worker (LHW)-delivered home-based package of care for alcohol 
dependence which addresses the acute care needs related to alcohol detoxification and 
the longer term goals of relapse prevention. Home-based detoxification has several 
potential benefits for low resource settings-continued routine life and social ties, 
detoxification within a familiar setting, with family support, continuation of work, 
support to family members, and less stigma (Fleeman, 1997). Finally, there is evidence 
from HICs that community detoxification as outlined above (fixed dose medication 
regimens, a carer overseeing the process, daily monitoring by trained staff, and 
psychosocial support) can be delivered by well-trained non-specialist health workers 
(Nadkarni et al., 2017a), and that well-trained non-specialist health workers can be 
recruited and utilised effectively within LMICs to undertake a range of health- and 
psychosocial-related tasks (Nadkarni et al., 2017b; van Ginneken et al., 2013).  
 
This paper describes the case series, one of the phases of the intervention development 
process, which aimed to demonstrate the acceptability, feasibility, and safety of the 
CONTAD package of care for alcohol dependence. The package of care was developed 
through a rigorous process developed in the study setting (Nadkarni et al., 2014) and 
included a) a systematic review to identify evidence-based components for the home-
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detoxification intervention (Nadkarni et al., 2017a), b) utilisation of a systematic review 
conducted in a different study which developed an intervention for harmful drinkers in 
the same setting (Nadkarni et al., 2015), c) qualitative interviews with patients with 
alcohol dependence, their family members, and clinicia s, and d) intervention 
development workshops at two de-addiction centres of xcellence in India.  
 
Materials and Methods 
 
Setting and target population  
Goa is a state on the west coast of India with a population of just over 1.4 million 
people (Government of India, 2011). The prevalence of current drinking among men 
attending primary care is 59% and the prevalence of hazardous drinking is 15% 
(D'Costa et al., 2007). 
 
This study was conducted in two settings: a) primary care clinics (5 in the public and 3 
in the private sector), and b) de-addiction centre in a secondary care district hospital. 
We only recruited males, because of the very low prevalence of AUD in women in 
India (Murthy et al., 2010).  
 
Study design 
Treatment cohort with before-and-after design. 
 
Sample  
As this was a proof of concept study we recruited a convenience sample of participants 
identified in four ways a) self-referral, b) referral by primary care physicians/GPs, c) 
universal screening in primary care, and d) referral f om secondary care de-addiction 
centre. All patients, except those referred from de-a diction centre, were administered 
the Alcohol Use Disorders Identification Test (AUDIT), a 10-item screening 
questionnaire developed by the World Health Organization for the detection of 
probable AUD (Saunders et al., 1993). It has been validated and used in India (Pal et 
al., 2004), and a vernacular version has been used extensively in the study settings 
(Nadkarni et al., 2017b). Adult (>18 years) male participants were eligible for inclusion 
in the study if they scored ≥20 on AUDIT indicating possible alcohol dependence. 
Participants who scored 16 to 19 (possible harmful drinkers) on the AUDIT were asked 
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follow-up questions to identify those with symptoms of alcohol withdrawal (Appendix 
1). Anyone screening positive on these follow-up questions was also included in the 
case series. Finally, any patient admitted to the secondary care de-addiction centre for 
inpatient detoxification was eligible for participation in the relapse prevention 
component after completion of the detoxification. Exclusion criteria included the 
following: age <18 years, difficulty with hearing or speaking which made interviewing 
difficult, inability to speak the local vernacular o English, or if the patient was in a 
critical condition and not able to answer assessment questions. 
 
Sampling and sample sizes  
As CONTAD aimed at treatment development, assessment of acceptability and 
feasibility of the intervention package and generation of preliminary estimates of 
impact, no formal sample size estimations were carried out. Sample size for the 
treatment cohort was based on experience of previous ntervention development 
projects, feasibility of recruitment and adequacy to meet study objectives.   
 
Procedures  
Consenting participants from primary care were assessed by the LHWs for preliminary 
eligibility (Appendix 2) to undergo home-detoxification. The primary care physician 
determined the final eligibility for home-based detoxification based on clinical 
examination and laboratory tests (Appendix 3). The eligibility criteria for home 
detoxification are listed in Box 1. Participants who were not eligible to undergo home-
detoxification at either of these assessments were referred to the de-addiction centre for 
inpatient detoxification. For participants eligible for home detoxification, the LHWs 
assessed the drinking history (Appendix 4), explained (verbal and written) the 
detoxification process to the patient and designated carer and obtained informed 
consent from both. The primary care physician then prescribed medications for home 
detoxification as per protocol, which was then monit red by the LHW. 
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LHWs 
Six female LHWs and one supervisor (also an LHW) participated in the study. 
They had no formal qualifications in the field of mental health, but had completed 
at least secondary school education. They underwent training in the home 
detoxification intervention and relapse prevention intervention for three days 
each. They also underwent a refresher training of four days, six months after the 
initial training. The training was delivered primarily by an experienced 
psychologist and psychiatrist. It was designed around the intervention manuals 
and included didactic lectures, videos, demonstrations and role plays. Some of the 
learning goals in the home detoxification training included understanding the 
features of alcohol dependence and alcohol withdrawal, learning how to do a 
detailed assessment of a person with alcohol dependnce, understand the role of 
various medications used in the alcohol detoxification process, learning how to 
measure blood pressure, pulse and temperature, learning how to identify 
nystagmus, ophthalmoplegia and ataxia, and learning how to check for orientation 
to time, space and person. The relapse prevention cou selling training focused on 
learning goals such as learning how to enhance motivation to change, identifying 
relapse triggers, helping the patients to deal with the triggers using skills such as 
handling peer pressure, and dealing with lapses and relapses. They received 
weekly peer-group supervision, which involved rating of randomly selected 
recorded sessions on the CONTAD Therapy Quality Scale (Appendix 5) 
developed specifically for the study.  
 
Interventions  
The interventions described below were delivered according to specific protocols 
developed for the program (http://www.sangath.in/cotad/). Home-detoxification 
involved once or twice daily home visits as per need, daily monitoring using the 
Clinical Institute Withdrawal Assessment for Alcohol, revised version (CIWA-
Ar) (Sullivan et al., 1989), monitoring of pulse, blood pressure, temperature, 
nystagmus, ophthalmoplegia, ataxia, dehydration, orientation, sleep, level of 
sedation, symptoms of delirium, side effects of medications, compliance with 
medications, and continued abstinence.  
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The designated carer and patient could contact the LHW over the phone or access 
the nearest hospital in case of any emergency, suchas a seizure. For patients 
undergoing home-detoxification, relapse prevention c unselling was commenced 
on completion of detoxification or as soon as the patient was physically 
comfortable during the course of the detoxification. For alcohol dependent 
patients who were currently not consuming alcohol and those who had completed 
detoxification at the de-addiction centre, the counselling was started as soon as the 
patient consented to participation. The counselling was delivered over 4-8 weeks 
through up to 4 sessions, each lasting 30-60 minutes. The content of the sessions 
included reviewing the patient’s drinking history and presenting personalised 
feedback, preparing to avoid a lapse by learning how to identify and deal with 
triggers, learning how to deal with a lapse, and learning what to do if a lapse 
turned into a relapse. A participant was classified as a `planned discharge' if at 
least one of the following criteria were met: participant's exit from treatment was 




The study was approved by the ethics committees at the implementing 
organisation, the Indian Council of Medical Research, and the state Directorate of 
Health Services. Anyone screening positive for hazardous or harmful drinking 
was provided a leaflet which specified the signs and risks associated with drinking 
problems, and listed self-help strategies to manage drinking. 
 
Data  
The following data were collected during the course of the study. 
(1) Process indicators: Data was collected on patients who screened positive, 
patients accepting treatment, those who refused treatment, and those who 
completed treatment. Information was also collected on adverse events, and 
dropouts. Serious adverse events were defined as any of the following: death 
due to any cause, attempted suicide, and unplanned hospitalisation.  
(2) Clinical indicators: Number of sessions, location of session delivery, 
duration of session, and number of days between sessions.  
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(3) Outcome assessment: Alcohol (in gms) consumed in the two weeks 
preceding the outcome assessment, heavy drinking days, and Short Inventory 
of Problems (SIP) score. The SIP is a 15-item questionnaire that measures 
physical, social, intrapersonal, impulsive, and interpersonal consequences of 
alcohol consumption. The SIP is a validated tool (Feinn et al., 2003) that has 
been used in the study setting (Nadkarni et al., 2017b). Alcohol consumption 
in the past two weeks and heavy drinking days were measured using the Time 
Line Follow Back (TLFB), a calendar tool supplemented by memory aids to 
obtain retrospective estimates of daily drinking over a specified time period. 
The TLFB is a validated instrument (Sobell and Sobell, 1992) that has been 
used in the study setting (Nadkarni et al., 2017b). The TLFB was used to 
calculate mean daily alcohol consumption and percentage days of heavy 
drinking (PDHD). These assessments were conducted at baseline and three 
months post recruitment. 
 
Analyses  
Process indicators of the screening, and treatment process are presented as 
proportions and means as appropriate. Socio-demographic characteristics of the 
sample are summarised as means and proportions as appropriate. The median pre 
and post scores on the outcome tools were compared using the Wilcoxon signed-
rank test. Sub-group analysis was conducted based on treatment completion, and 
type of treatment (detoxification and relapse prevention vs relapse prevention 




Feasibility of screening in primary care and acceptability of recruitment 
procedures to patients in primary care 
 
Participants were recruited through a sequential process (Fig 1). We gained access 
to 7013 patients, 1000 (14.3%) in the private-sector linics and 6013 (85.7%) in 
the public-sector clinics, through universal screening or referrals. Of these, 5006 
(71.4%) agreed to be assessed for eligibility for screening, and 3251 (64.9%) were 
eligible for screening. Of the 3251 screened, 2225 (68.4%) were ever drinkers and 
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1414 (43.5%) were current drinkers. Two thirds (63.6%) of the ever drinkers were 
current drinkers. The mean AUDIT score amongst current drinkers was 8.5 
(SD=7.4) and the prevalence of alcohol dependence amongst current drinkers was 
140 (10.1%).  
 
35 harmful drinkers were also screened using the additional questions and based 
on that 22 (62.9%) were diagnosed to have alcohol dependence. Additionally, 
seven participants were recruited in the public-sector linics immediately after 
inpatient detoxification in the tertiary care de-addiction centre. One participant did 
not agree to the consenting process. Of the remaining 168 with alcohol 
dependence, 38 (22.6%) consented to participate in he study. Despite screening 
positive for alcohol dependence on the AUDIT, 27 were currently abstinent and 
did not have any acute withdrawal symptoms (seven after  recently completed 
inpatient detoxification), and 11 were currently consuming alcohol. The former 
were directly recruited to receive relapse prevention counselling, and the latter 
were recruited to receive home detoxification followed by relapse prevention 
counselling. 
 
There were no statistically significant differences between those who consented to 
participate and those who did not; and amongst those who consented to participate 
there were no significant differences between those recruited from the public 
sector clinics and those recruited from the private sector clinics (Supplementary 
tables 2 and 3). 
 
Acceptability, feasibility, and safety of medically assisted detoxification by 
LHWs in patients’ homes 
 
11 participants started detoxification. Their mean age was 38.2 (SD=10.6) years 
and mean AUDIT score was 24.9 (SD=9.0); the predominant proportion had at 
least some education (81.8%), were employed (81.8%), married (81.8%) and 
recruited in the public sector clinics (81.8%) (Supplementary Table 5). One 
participant (9.1%) was excluded after day four as he re-started consuming alcohol. 
Six participants completed detoxification on day five, and two participants each 
completed detoxification on day six and day seven respectively. 
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Table 1 describes the CIWA-Ar scores and figures 2a and 2b describe the clinical 
indicators through the course of the detoxification. The severity of withdrawal 
was predominantly mild to moderate, and the severity steadily decreased over the 
course of the detoxification. All clinical parameters that were assessed either 
remained within the normal range (Pulse, BP, temperature) or normalized if it was 
abnormal (ataxia, dehydration, disorientation, sleep) over the course of the 
detoxification.  
 
During the course of the detoxification, two serious adverse events were reported, 
both unplanned hospitalisations. In one case the admission was for severe 
tremulousness, which was misinterpreted by the carer as a seizure. An assessment 
of the other serious adverse event could not be made as the patient did not agree 
for a formal evaluation of the serious adverse event by a specialist, despite 
multiple requests.  
 
Acceptability and feasibility of relapse prevention counselling by LHWs 
 
Of the 38 who entered relapse prevention treatment, 15 (39.5%) completed 
treatment or had a planned discharge. There were no statistically significant 
differences on intake variables between those who completed treatment or had a 
planned discharge compared to those who dropped out of treatment 
(Supplementary table 4). There were no statistically significant differences on 
intake variables between those who received detoxification and relapse prevention 
compared to those who received only relapse prevention (Supplementary table 5). 
 
Details of the relapse prevention counselling are described in Table 2 and Table 3. 
Of the 38 participants who entered treatment, 2 (5.3%) dropped out before starting 
relapse prevention counselling, 10 (26.3%) completed all four sessions, 8 (21.1%) 
completed three sessions, 5 (13.2%) completed two sessions, and 13 (34.2%) 
completed one session. The mean number of sessions was 2.4 (SD=1.3) after 
excluding the two who did not get a single session. Those who had a planned 
discharge received on an average 3.7 (SD 0.5) sessions and those who dropped 
out received on an average 1.4 (SD 0.8) sessions. There were no significant 
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differences in mean number of sessions and mean duration of treatment between 
those who received detoxification and relapse prevention compared to those who 
only received relapse prevention. The mean duration of sessions reduced from 
session 1 to session 3 before increasing again in the final session. The highest 
proportion of session 1 was conducted in the clinic and this proportion gradually 
reduced over the duration of treatment, with the highest proportion of session 4 
conducted in the patients’ homes. Finally, the mean number of days between 
sessions increased as the treatment progressed from session 1 to session 4 (from 
16 to 31 days). 
 
Feasibility of measuring drinking and related outcomes (Tables 4a and 4b) 
 
At baseline, TLFB was available for 36 (94.7%) participants and SIP was 
available for 32 (84.2%) participants. At follow-up, TLFB and SIP were available 
for 35 (92.1%) participants. There was no significant difference in daily alcohol 
consumption and PDHD between baseline and follow-up in the whole cohort and 
when segregated by treatment settings, severity of dependence, and number of 
sessions attended. However, there was a significant difference between baseline 
and follow-up in a) daily alcohol consumption in those who completed treatment 
(Median 20.7 vs 0, p=0.04), b) PDHD in those who received home detoxification 
and relapse prevention counselling (Median 35.7 vs 0, p=0.006),  c) SIP scores in 
the whole cohort (24.5 vs 15.0, p=0.002), in those with milder alcohol dependence 
(Median 24.0 vs 10.0, p=0.02), those who attended more sessions (Median 26.5 vs 
15.0, p=0.02), and those who dropped out of treatmen  (Median 24.5 vs 22.0, 
p=0.03). 
 
Adaptations to the home detoxification manual 
 
Some of the learnings during the course of the study hat resulted in adaptations to 
the detoxification are described in Table 5.  
 
Discussion 
Our study examines the acceptability, feasibility, and safety of a contextually-
adapted package for home detoxification and relapse prevention delivered by lay 
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health workers, the first such study from India. Our findings indicate that it is 
feasible to identify and recruit patients with alcohol dependence into a programme 
that delivers home detoxification and relapse prevention counselling through 
LHWs. Importantly, such a programme is acceptable to the recipients to some 
extent, is feasible and safe to deliver.  
 
Our study had a low consent and a high dropout rate, with only 40% of those 
entering the programme completing treatment. Low rates of entry into and high 
dropout rates from substance misuse treatment are not unusual. In better resourced 
settings, such as in Europe, <20% of all AUD cases id ntified, receive treatment 
for their alcohol problems in the 12 months preceding identification (Manthey et 
al., 2016); and treatment contact is reported to be no more than 20% in the year of 
onset, even for alcohol dependence (Oakley Browne et al., 2006; Wang et al., 
2005). Some common reasons for not entering treatment for AUD include beliefs 
that one should be strong enough to handle their drinking problem by themselves, 
that drinking problems resolve by themselves, and that one’s drinking problem is 
not serious enough require treatment (Grant, 1997). High drop-out rates are not 
unique to AUDs, with rates being as high (31-60%) for a range  of  other mental  
health  treatment  programmes (Keil and Esters, 1982). More specifically, 
completion rates for standard outpatient adult alcohol treatment programmes are 
as low as 40% (Wickizer et al., 1994). 
 
On the other hand, we observed high completion rates for the home detoxification 
component of our study. The detoxification process was largely clinically 
uneventful, patients and their carers adhered to the protocol, and there were no 
serious adverse events resulting directly from the detoxification. This is consistent 
with findings reported in other studies (Nadkarni et al., 2017a). The impact of 
home detoxification has been examined using a range of study designs. In 
experimental studies, those who underwent community de oxification (compared 
to patients undergoing facility-based detoxification) were more likely to be 
drinking less or abstinent (Nadkarni et al., 2017a). In non-controlled studies of 
home detoxification such as ours there was a significa t reduction in quantity and 




The only other study that examined community detoxification in a LMIC was 
conducted in Brazil and  compared conventional outpatient treatment for alcohol 
dependence with conventional outpatient treatment supplemented by home visits. 
(Moraes et al., 2010). The latter was superior with regard to a range of clinical 
outcomes. In the absence of an evidence base from LMICs, our study is crucial as 
it demonstrates the workability of a potential soluti n to bridging the AUD 
treatment gap in a low-resource setting. In our study there was a significant 
difference between baseline and follow up for daily a cohol consumption and 
heavy drinking in those who received both home detoxification and relapse 
prevention counselling, but not in those who received only the latter. We also 
observed a similar significant difference in the SIP scores, in the whole cohort, in 
those who had milder alcohol dependence, had a longer duration of treatment, and 
attended more sessions. All of these findings, combined with the low mean 
number of sessions received, indicate the need for ongoing care to improve 
outcomes in alcohol dependence. It is possible thatwhen the same LHWs 
undertake both detoxification and relapse prevention c unselling it is much more 
likely to be successful because these LHWs have been visiting the patient in their 
home, and have made positive therapeutic relationshps with both the patient and 
their carer. On the other hand, if the patient is detoxed in a facility, separated both 
geographically and in its orientation with CONTAD, then there may be far less 
engagement with the relapse prevention counselling. 
 
Historically, treatments for AUD have been delivered for circumscribed duration 
or intensity, and are expected to produce impact lasting well beyond the end of 
treatment. However, this is in contrast to treatments of other chronic medical 
conditions which include acute care strategies followed by longer-term follow-up 
and strategies. Thus, in AUD, we may be missing opportunities to maximise the 
potential benefits of existing treatments by focusing on interventions delivered in 
a few sessions over a short period of time (McLellan, 2002). A more appropriate 
response for alcohol dependence would be to maintain therapeutic contact for 
extended periods of time and to adjust the intensity of treatment in response to 
changes in symptoms and functioning over time (McKay, 2005). A study from 
India in which the intervention group received weekly continued care in the 
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community, compared to routine hospital follow-up visits, showed that the former 
group had more non-drinking days and that they continued to maintain these gains 
while the control group showed a downward slide (Murthy et al., 2009). Thus one 
of the adaptations that will have to be made to the CONTAD relapse prevention 
intervention is to individualise treatment planning so that the length of follow up 
care can be matched to patient requirements in order to achieve sustained change 
in drinking outcomes. 
 
The other major adaptation would have to be around strategies to engage and 
retain patients in treatment. These could include strategies implemented before 
treatment begins (e.g. reviewing potential barriers to adherence) and those 
implemented during treatment (e.g. calling up patients to check on their status on 
the same day that they miss a session) (Carroll, 1997). These are in addition to the 
strategies that are already specified in the manual, s ch as exploring ambivalence 
and encouraging the involvement of significant others. Finally, in our study, the 
primary care physicians were very well engaged with their tasks of examining the 
patient’s eligibility for home detoxification and prescribing medications. 
However, they could potentially play a greater role in a collaborative care model 
where they contribute to other critical processes such as supervision of the LHWs. 
On the other hand, such compliance in dealing with alcohol withdrawal and 
detoxification certainly cannot be taken for granted, and it is very likely that a 
coordinated education and attitude-modification program would be needed in 
order to roll out methods such as these into routine clinical practice within 
primary care. 
 
This is a first study from India examining the feasibility, acceptability, and safety 
of an intervention package for alcohol dependence delivered by LHWs in the 
community. Its strengths lie in its participatory methods used to design  the 
intervention, primary care approach to recruitment, and innovative delivery 
method. Our study has weaknesses as well and these ne d to be considered while 
interpreting our findings. The sample size limits the precision of our findings and 
the absence of a control arm means that we cannot attribute any changes in the 
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outcome measures directly to the intervention. Another limitation is the use of 
AUDIT to identify alcohol dependence. The cut-off score to identify alcohol 
dependence has not been well validated, but a cut off sc re of 20 is in line with 
expert guidance on the use of this instrument, and dependence has been identified 
in primary care populations at lower scores (Johnson et al., 2013). This limitation 
was offset to a certain extent in our study by using additional questions which 
allowed us to use symptomatology to identify alcohol dependence that might have 
been missed by the AUDIT. Our stringent eligibility criteria ensured that only 
those with less severe alcohol dependence were included in the study. Although 
this limits the generalisability of our findings, it ensured that patients having 
complex alcohol dependence with the potential for adverse outcomes were not put 
at risk by undergoing detoxification in settings with l mited medical supervision.   
 
The evidence base for treatment of alcohol dependence, both for home 
detoxification and relapse prevention, is predominantly derived from high-income 
countries and is focused on specialist settings and delivery (Allen et al., 1997; 
Nadkarni et al., 2017a; World Health Organization, 2015; UKATT Research 
Team, 2005). Hence, CONTAD is unique as it is designed to be delivered by 
LHWs in primary care settings, making it potentially scalable in low resource 
settings with shortage of specialist healthcare professionals. Considering the 
feasibility, acceptability, and safety of CONTAD and the encouraging change in 
some outcomes in the positive direction, further research on CONTAD is 
warranted. This could include a trial of CONTAD, adapted based on the findings 
of this formative research. If effective, such a contextually-appropriate 
intervention for alcohol dependence could be a substantial achievement as it is the 
first comprehensive intervention for alcohol dependence developed in a LMIC 
and is designed to meet the acute care and longer term needs of those with alcohol 
dependence. Finally, if effectiveness of CONTAD is e tablished, further 
implementation science research would help test the scalability of the intervention 
inherent in its suitability for non-specialist health worker delivery and processes 
such as peer-supervision. In conclusion, our findings warrant further research on 
CONTAD as it has the potential to bridge the significant treatment gap for alcohol 
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Box 1: Eligibility criteria for home detoxification 
All these criteria to be fulfilled Contraindications for home detoxification 
 Assessed by LHW Assessed by primary care physician 
Age >18 years 
Stable housing  
Designated carer available and willing to stay with 
the patient  
Patient agreeable for home visit/contact by the LHW  
Appropriate care arrangements put in place for any 
children and vulnerable adults  
Lifetime: 
Seizures or severe confusion during a past 
detoxification  
History of hallucinations 
Unexplained loss of consciousness 
Seizures even when not withdrawing from alcohol or 
on treatment for epilepsy 
 
Current: 
Treatment for psychiatric disorder 
Use of any other substance of misuse (except 
tobacco)  
Head injury with loss of consciousness in the past one 
year 
Blood in the stool in the past one year 
Blood in vomitus in the past one year 
Lifetime: 
Wernicke’s encephalopathy 
Angina/coronary heart disease 
 
Current: 
On regular benzodiazepines  
Wernicke’s encephalopathy 
Physical health problems requiring immediate 
medical/surgical attention 
Unstable medical/psychiatric conditions  
Signs of liver compromise  
Severely dehydrated  
Cerebrovascular accident in the past one year 
Recent cardiac event 
Untreated/uncontrolled hypertension  




Table 1: Clinical indicators of home detoxification 





















Mean CIWA-Ar score (SD) 8.5 (5.0) 5.5 (4.1) 4.8 (4.7) 3.5 (4.3) 2.4 (3.2) 0 (0) 0 (0) 
CIWA-Ar <8 (mild 
withdrawal) n (%) 
5 (45.5) 8 (72.7) 9 (81.8) 10 (90.9) 10 (100.0) 4 (100.0) 2 (100.0) 
CIWA-Ar 9-15 (moderate 
withdrawal) n (%) 
4 (36.4) 3 (27.3) 2 (18.2) 1 (9.1) 0 (0) 0 (0) 0 (0) 
CIWA-Ar >15 (severe 
withdrawal) n (%) 
2 (18.2) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Clinical Institute Withdrawal Assessment of Alcohol Scale, Revised (CIWA-Ar), Standard Deviation (SD) 
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Table 2: Details of relapse prevention counselling 













Session 1 36 (94.7) 49.6 (19.3) Clinic 22 (61.1)  
Home 14 (38.9) 
Session 2 24 (66.7) 40.2 (11.9) Clinic 11 (45.8) 15.5 (15.7) 
Home 13 (54.2) 
Session 3 18 (72.0) 34.7 (7.7) Clinic 7 (38.9) 19.8 (14.0) 
Home 10 (55.6) 
Phone 1 (5.6) 
Session 4 10 (55.6) 41.8 (12.3) Clinic 2 (20.0) 30.8 (20.6) 
Home 7 (70.0) 
Phone 1 (10.0) 














































69.0 (38.7) 76.7 
(40.8) 
57.2 (33.3) 0.13 73.4 (37.3) 58.1 (41.9) 0.27 
Standard Deviation (SD) 
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 Table 4a: Comparison of drinking and its impact at baseline and follow up  








































 32.5 (0-135.3)  4.1 (0-69.9)  47.9 (0-
135.3) 




Baseline 28.6 (0-100) 0.64 17.9 (0-100) 0.21 35.7 (14.3-100) 0.006 28.6 (0-
100) 
0.42 21.4 (0-85.7) 0.05 
 Follow 
up 
7.1 (0-100)  7.1 (0-100)  0.0 (0-100)  42.9 (0-
100) 




Baseline  24.5 (3-44) 0.002 24.5 (5-44) 0.02 25.0 (3-42) 0.04 24.5 (3-42) 0.03 26.5 (10-44) 0.05 
 Follow 
up 
15.0 (0-41)  22.0 (0-41)  12.5 (0-39)  22.0 (0-41)  12.5 (0-39)  




Table 4b: Comparison of drinking and its impact at baseline and follow up 

















Median daily alcohol consumed in gms 
(Range)  
Baseline 25.2 (0-105.9) 0.07 13.3 (0-281.5) 0.29 35.0 (0-149.3) 0.42 18.2 (0-281.5) 0.19 
 Follow 
up 
2.8 (0-135.3)  51.4 (0-119.1)  42.3 (0-135.3)  0.0 ( -96.2)  
Median PDHD (Range) Baseline 28.6 (0-100) 0.07 14.3 (0-85.7) 0.09 32.1 (0-100) 0.70 21.4 (0-100) 0.32 
 Follow 
up 
0.0 (0-100)  39.3 (0-92.9)  35.7 (0-100)  0.0 (0-10)  
Median SIP score (Range) Baseline  24.0 (3-44) 0.02 30.0 (17-42) 0.1 22.0 (3-42) 0.10 26.5 (10-44) 0.02 
 Follow 
up 
10.0 (0-38)  25.5 (5-41)  22.0 (0-41)  15.0 (0-39)  
Alcohol Use Disorder Identification Test (AUDIT), Percentage days heavy drinking (PDHD), Short Inventory of Problems (SIP) aExcluding 7 participants who were eligible 




 Table 5: Adaptations made to the detoxification manual 
Observation Adaptation 
Although past history of seizure was a 
criterion for exclusion from home 
detoxification we unknowingly included  
one patient with such a history as the patient 
and his carer assured us that he had never 
had ‘fits’ before. It became obvious that 
everyone in the target population did not 
clearly understand how a seizure presented. 
Instead of asking the patient and carer 
whether the former ever experienced a ‘fit’ 
we started asking them the following: ‘Have 
you ever observed or has anyone reported 
an event where (the patient’s) limbs became 
stiff and then started shaking violently, after 
which you lost consciousness, involuntarily 
passed urine, frothed at the mouth, bit your 
tongue and became unconscious?’ 
Certain medications (e.g. Omeprazole, 
Chlordiazepoxide) that we had specified in 
our original manual, based on the evidence 
and treatment development workshops, 
were not available in the public sector 
clinics. 
We revised the protocol to ensure that 
alternative medications already available in 
the clinic (e.g. Ranitidine, Diazepam) were 
pecified for the primary medications if the 
latter were not available. 
Certain eligibility criteria for home 
detoxification that the doctors had to check 
for were too vague for the doctors and they 
communicated that to us e.g. ‘Currently 
unstable medical conditions’ 
The criteria which were reported to be 
vague were made more specific to make 
them clearer. 
Patients and their carers found it difficult to 
negotiate the dosing schedules of the 
various medications. 
We used small envelopes with the tablets to 
be taken at particular times of the day and 
details of the medications were written on 














Figure 1: Flow diagram of progress through the phases of the treatment cohort 
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-Alcohol detoxification can be safely delivered at home by LHW 
-Entry and retention into treatment for alcohol dependence (AD) is modest 
-LHW delivered interventions for AD could potentially reduce the impact of the AD 
